Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.78 billion. The enterprise value is $1.79 billion.
| Market Cap | 1.78B |
| Enterprise Value | 1.79B |
Important Dates
The next estimated earnings date is Tuesday, May 28, 2024, before market open.
| Earnings Date | May 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 47.98 million shares outstanding. The number of shares has increased by 2.75% in one year.
| Shares Outstanding | 47.98M |
| Shares Change (YoY) | +2.75% |
| Shares Change (QoQ) | +25.21% |
| Owned by Insiders (%) | 22.17% |
| Owned by Institutions (%) | 40.37% |
| Float | 35.35M |
Valuation Ratios
The trailing PE ratio is 28.58 and the forward PE ratio is 24.56.
| PE Ratio | 28.58 |
| Forward PE | 24.56 |
| PS Ratio | 1.28 |
| Forward PS | 0.99 |
| PB Ratio | 2.88 |
| P/FCF Ratio | 44.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.41, with an EV/FCF ratio of 45.17.
| EV / Earnings | 29.53 |
| EV / Sales | 1.29 |
| EV / EBITDA | 13.41 |
| EV / EBIT | 16.48 |
| EV / FCF | 45.17 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.52.
| Current Ratio | 2.11 |
| Quick Ratio | 1.98 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 2.40 |
| Debt / FCF | 8.09 |
| Interest Coverage | 6.76 |
Financial Efficiency
Return on equity (ROE) is 10.50% and return on invested capital (ROIC) is 5.93%.
| Return on Equity (ROE) | 10.50% |
| Return on Assets (ROA) | 6.00% |
| Return on Capital (ROIC) | 5.93% |
| Revenue Per Employee | $770,367 |
| Profits Per Employee | $33,732 |
| Employee Count | 1,800 |
| Asset Turnover | 1.38 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $31.99 million in taxes.
| Income Tax | 31.99M |
| Effective Tax Rate | 34.51% |
Stock Price Statistics
The stock price has increased by +5.91% in the last 52 weeks. The beta is 1.09, so Astrana Health's price volatility has been similar to the market average.
| Beta (1Y) | 1.09 |
| 52-Week Price Change | +5.91% |
| 50-Day Moving Average | 40.62 |
| 200-Day Moving Average | 36.19 |
| Relative Strength Index (RSI) | 38.44 |
| Average Volume (30 Days) | 155,829 |
Short Selling Information
The latest short interest is 2.67 million, so 5.56% of the outstanding shares have been sold short.
| Short Interest | 2.67M |
| Short Previous Month | 2.73M |
| Short % of Shares Out | 5.56% |
| Short % of Float | 7.55% |
| Short Ratio (days to cover) | 20.56 |
Income Statement
In the last 12 months, Astrana Health had revenue of $1.39 billion and earned $60.72 million in profits. Earnings per share was $1.29.
| Revenue | 1.39B |
| Gross Profit | 214.96M |
| Operating Income | 84.61M |
| Pretax Income | 92.71M |
| Net Income | 60.72M |
| EBITDA | 133.74M |
| EBIT | 108.81M |
| Earnings Per Share (EPS) | $1.29 |
Balance Sheet
The company has $296.31 million in cash and $321.01 million in debt, giving a net cash position of -$24.71 million or -$0.51 per share.
| Cash & Cash Equivalents | 296.31M |
| Total Debt | 321.01M |
| Net Cash | -24.71M |
| Net Cash Per Share | -$0.51 |
| Equity / Book Value | 614.22M |
| Book Value Per Share | 12.80 |
| Working Capital | 242.83M |
Cash Flow
In the last 12 months, operating cash flow was $68.23 million and capital expenditures -$28.53 million, giving a free cash flow of $39.70 million.
| Operating Cash Flow | 68.23M |
| Capital Expenditures | -28.53M |
| Free Cash Flow | 39.70M |
| FCF Per Share | $0.68 |
Margins
Gross margin is 15.50%, with operating and profit margins of 6.10% and 4.38%.
| Gross Margin | 15.50% |
| Operating Margin | 6.10% |
| Pretax Margin | 6.69% |
| Profit Margin | 4.38% |
| EBITDA Margin | 9.64% |
| EBIT Margin | 7.85% |
| FCF Margin | 2.86% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.75% |
| Shareholder Yield | -2.75% |
| Earnings Yield | 3.43% |
| FCF Yield | 2.24% |
Analyst Forecast
The average price target for Astrana Health is $44.00, which is 18.69% higher than the current price. The consensus rating is "Hold".
| Price Target | $44.00 |
| Price Target Difference | 18.69% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 27, 2015. It was a reverse split with a ratio of 1:10.
| Last Split Date | Apr 27, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
Astrana Health has an Altman Z-Score of 4.58 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.58 |
| Piotroski F-Score | 5 |